In the vast world of biomedical research, the humanized model of the immune system has always been a realistic and comprehensive experimental environment pursued by researchers. With the advancement of science and technology, iHuPBMC-OncVax model of InnoModels Biotechnology contributes to drug research and development with its unique advantages.
The greatest advantage of the iHuPBMC-OncVax model is its comprehensive immune cell reconstruction capability. Traditional PBMC models often only reconstruct human-derived T cells or NK cells, which undoubtedly limits their application in actual drug evaluation. The iHuPBMC-OncVax model, on the other hand, is able to reconstruct human T cells, B cells, NK cells, macrophages, and DC cells in mice, constructing a comprehensive and realistic immune system environment.
This comprehensive immune cell reconstruction provides more realistic and effective experimental conditions for drug evaluation. In the process of drug development, scientists need to evaluate the effects of drugs on the immune system through experiments to determine their efficacy and safety. The comprehensive immune system constructed by the iHuPBMC-OncVax model allows scientists to more accurately simulate the response of drugs in the human body, providing more reliable experimental data for drug development.

In addition, the iHuPBMC-OncVax model is able to fulfill the critical need of antigen delivery. In the traditional PBMC model, antigen presentation is not possible due to the lack of reconstruction of human-derived myeloid cells, which undoubtedly restricts its application in immunological research. The iHuPBMC-OncVax model, on the other hand, realizes the function of antigen presentation through the reconstruction of human-derived macrophages, which allows scientists to study the mechanism of drug effects on the immune system in greater depth.
In summary, the iHuPBMC-OncVax model of InnoModels Biotechnology provides a more realistic and effective experimental environment for drug discovery and development with its comprehensive immune cell reconstruction capability and antigen-presenting function. This unique advantage not only promotes a new chapter in drug discovery and development, but also injects new vitality into the development of biomedical research. We expect this model to play a greater role in future drug development and make greater contributions to human health.